Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer
- 1 April 2017
- journal article
- review article
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 64, 98-106
Abstract
No abstract availableKeywords
Funding Information
- J. Randall & Kathleen L. MacDonald Kidney Cancer Research Fund
This publication has 107 references indexed in Scilit:
- Emerging landscape of oncogenic signatures across human cancersNature Genetics, 2013
- Integrated molecular analysis of clear-cell renal cell carcinomaNature Genetics, 2013
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell CarcinomaEuropean Urology, 2013
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- mTOR Inhibitors in Advanced Renal Cell CarcinomaHematology/Oncology Clinics of North America, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- International network of cancer genome projectsNature, 2010
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialThe Lancet, 2008
- The Hallmarks of CancerCell, 2000